Stem cell therapies as a therapeutic option to counter chemo brain: a negative effect of cancer treatment

Regen Med. 2020 Jun;15(6):1789-1800. doi: 10.2217/rme-2020-0060. Epub 2020 Aug 26.

Abstract

Chemo brain, a constellation of cognitive deficiencies followed by chemotherapy drugs, used to treat different types of cancers and adversely impacts the quality of life of a cancer survivor. The underlying mechanism of chemo brain remains vague, thus delaying the advancement of efficient treatments. Unfortunately, there is no US FDA approved medicine for chemo brain and often medicines considered for chemo brain are already the ones approved for other diseases. Nevertheless, researches exploring stem cell transplantation in different neurodegenerative diseases demonstrate that cellular transplantation could reverse chemotherapy-induced chemo brain. This review talks about the mechanism behind the cognitive impairments instigated by different chemotherapy drugs used in cancer treatment, and how stem cell therapy could be advantageous to overcome this disease.

Keywords: cancer; chemo brain; chemotherapy drugs; cognitive impairments; stem cells.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Brain Diseases / chemically induced
  • Brain Diseases / pathology
  • Brain Diseases / therapy*
  • Cancer Survivors / psychology*
  • Humans
  • Neoplasms / complications*
  • Quality of Life*
  • Stem Cell Transplantation / methods*
  • Stem Cells / cytology*

Substances

  • Antineoplastic Agents